ORAL PHARMACEUTICAL EXTENDED RELEASE DOSAGE FORM

摘要

An enteric coated pharmaceutical extended release dosage form of an H+,K+- ATPase inhibitor giving an extended plasma concentration profile of an H+,K+-ATPase inhibitor. The extended plasma profile is obtaine d by a pharmaceutical composition which comprises a core material of a hydrophilic or hydrophobic matrix, and the H+,K+-ATPase inhibitor and optionally pharmaceutically acceptable excipients. The dosage form may be administered once daily.